Status:
COMPLETED
Genetic Identification of Monogenic Disorders in Early-onset Stroke Using Targeted Next Generation Sequencing Panel
Lead Sponsor:
Beijing Tiantan Hospital
Collaborating Sponsors:
Beijing Municipal Science & Technology Commission
Conditions:
Stroke, Acute
Transient Ischemic Attack
Eligibility:
All Genders
18-45 years
Brief Summary
The study was designed as a multicenter multiracial prospective observational study of acute ischemic stroke and TIA patients across china. The purpose of this study is to determine the monogenic diso...
Detailed Description
The study was designed as a multicenter multiracial prospective observational study of acute ischemic stroke and TIA patients across china. The purpose of this study is to determine the monogenic diso...
Eligibility Criteria
Inclusion
- Provision of informed consent.
- Female or male aged ≥ 18 years and ≤ 45 years.
- Acute ischemic stroke or Transient ischemic attack((Neurological deficit attributed to focal brain ischemia, with resolution of the deficit within 24 hours of symptom onset) patients that can be enrolled within 7 days of symptoms onset defined by the"last see normal"principle.
Exclusion
- Asymptomatic brain infarction
- Neurological deficit due to causes other than ischemic stroke or TIA
Key Trial Info
Start Date :
August 21 2015
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 22 2020
Estimated Enrollment :
502 Patients enrolled
Trial Details
Trial ID
NCT04485598
Start Date
August 21 2015
End Date
May 22 2020
Last Update
July 24 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Beijing Tian Tan Hospital, Capital Medical University
Beijing, Beijing Municipality, China, 100050